Larimar Therapeutics, Inc. is a clinical-stage biotechnology firm headquartered in Bala Cynwyd, Pennsylvania, dedicated to advancing innovative therapies for rare diseases. The company primarily focuses on developing treatments that address significant unmet medical needs, utilizing cutting-edge technologies and scientific insights to enhance patient outcomes. With a promising pipeline and strategic partnerships, Larimar aims to establish itself as a leader in the rare disease space while delivering value to its stakeholders.